Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 2
2001 3
2006 1
2007 2
2008 3
2015 3
2016 4
2017 3
2018 2
2019 3
2020 5
2021 5
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease.
Leta V, Klingelhoefer L, Longardner K, Campagnolo M, Levent HÇ, Aureli F, Metta V, Bhidayasiri R, Chung-Faye G, Falup-Pecurariu C, Stocchi F, Jenner P, Warnecke T, Ray Chaudhuri K; International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Leta V, et al. Among authors: chung faye g. Eur J Neurol. 2023 May;30(5):1465-1480. doi: 10.1111/ene.15734. Epub 2023 Mar 7. Eur J Neurol. 2023. PMID: 36757008 Review.
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Kennedy NA, et al. Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. doi: 10.1016/S2468-1253(19)30012-3. Epub 2019 Feb 27. Lancet Gastroenterol Hepatol. 2019. PMID: 30824404
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, Bewshea CM, Chanchlani N, Walker GJ, Perry MH, McDonald TJ, Lees CW, Cummings JRF, Parkes M, Mansfield JC, Irving PM, Barrett JC, McGovern D, Goodhand JR, Anderson CA, Ahmad T; PANTS Consortium. Sazonovs A, et al. Gastroenterology. 2020 Jan;158(1):189-199. doi: 10.1053/j.gastro.2019.09.041. Epub 2019 Oct 7. Gastroenterology. 2020. PMID: 31600487 Free article.
Colorectal cancer screening.
Hayee BH, Chung-Faye G. Hayee BH, et al. Among authors: chung faye g. Clin Med (Lond). 2006 Sep-Oct;6(5):453-6. doi: 10.7861/clinmedicine.6-5-453. Clin Med (Lond). 2006. PMID: 17080891 Free PMC article. Review. No abstract available.
Gene therapy for colorectal cancer: therapeutic potential.
Chen MJ, Chung-Faye GA, Searle PF, Young LS, Kerr DJ. Chen MJ, et al. Among authors: chung faye ga. BioDrugs. 2001;15(6):357-67. doi: 10.2165/00063030-200115060-00002. BioDrugs. 2001. PMID: 11520247 Review.
Gene therapy strategies for colon cancer.
Chung-Faye GA, Kerr DJ, Young LS, Searle PF. Chung-Faye GA, et al. Mol Med Today. 2000 Feb;6(2):82-7. doi: 10.1016/s1357-4310(99)01598-1. Mol Med Today. 2000. PMID: 10652481 Review.
41 results